Genomics Market by Product and Service (Systems & Software, Consumables, Services), Technology (Sequencing, Microarray, PCR), Application (Diagnostic Application, and Precision Medicine), End User (Research Institute) - Global Forecast to 2024
[218 Pages Report] The global genomics market is projected to reach USD 35.7 billion by 2024 from USD 18.9 billion in 2019, at a CAGR of 13.5% during the forecast period. Factors such as the rising government funding and growth in the number of genomics projects, decreasing sequencing costs, growing application areas of genomics, and the entry of new players and start-ups in the genomics field are driving the growth of the market. However, the high cost of genomic equipment could limit market growth to a certain extent in the coming years.
The consumables segment dominated the genomics market, by product & service, in 2018
On the basis of product & service, the market is segmented into consumables, systems & software, and services. In 2018, the consumables segment accounted for the largest share of the market; whereas, the services segment is expected to register the highest growth during the forecast period. The high growth of the services segment is attributed to the rising number of genomic services start-ups.
The PCR segment accounted for the largest share of the genomics market, by technology, in 2018
On the basis of technology, the market is segmented into sequencing, microarray, PCR, nucleic acid extraction and purification, and other technologies (such as branched DNA analysis, single-cell genomic analysis, and flow cytometry). The PCR segment accounted for the largest share of the market in 2018. Technological advancements, increasing research in the field of genomics, and the lower cost of DNA amplification using PCR are the key factors driving the growth of this market.
Diagnostics forms the largest and fastest-growing application segment in the genomics market
On the basis of application, the market is segmented into diagnostics, drug discovery and development, personalized medicine, agriculture and animal research, and other applications (such as forensics and biofuel research). Diagnostics is the largest and the fastest-growing application segment in the market. Growth in this segment can be attributed to the increasing research on diseases such as cancer and genetic disorders and the decreasing cost of sequencing.
Increasing research intensity to drive the usage of genomic systems among academic & government institutes
On the basis of end user, the market is segmented into research centers and academic & government institutes, hospitals and clinics, pharmaceutical and biotechnology companies, and other end users. The research centers and academic & government institutes segment accounted for the largest share of the market in 2018. The large share of this segment can be attributed to the increase in research intensity in this end-user segment and the rising funding for research.
North America to account for the largest share of the genomics market during the forecast period
North America accounted for the largest share of the genomics market in 2018. The large share of North America is attributed to the increasing research funding and government initiatives in genomics. The Asia Pacific market, on the other hand, is expected to register the highest CAGR during the forecast peri
Thermo Fisher Scientific, Inc. (US), Illumina, Inc. (US), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (US), Eurofins Scientific (Germany), BGI (China), GE Healthcare (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), and Oxford Nanopore Technologies (UK) are the key players operating in the market.
Scope of the Report
|
Report Metric |
Details |
|
Market Size Available for Years |
20172024 |
|
Base Year Considered |
2018 |
|
Forecast Period |
20192024 |
|
Forecast Units |
Value (USD) |
|
Segments Covered |
Product & Service, Technology, Application, End User, and Region |
|
Geographies Covered |
North America (US & Canada), Europe (UK, Germany, France, & RoE), Asia Pacific (China, India, Japan, and Rest of APAC), RoW (Latin America and the Middle East and Africa) |
|
Companies Covered |
Major 12 players covered, including Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), QIAGEN (Netherlands), and Eurofins Scientific (Germany) |
This research report categorizes the market based on product & service, application, end user, and region.
On the basis of Product & Service, the genomics market has been segmented as follows:
- Consumables
- Systems and software
- Services
On the basis of Technology, the genomics market has been segmented as follows:
- Sequencing
- Microarray
- PCR (polymerase chain reaction)
- Nucleic acid extraction and purification
- Other technologies (such as branched DNA analysis, single-cell genomics analysis, and flow cytometry)
On the basis of Application, the genomics market has been segmented as follows:
- Diagnostics
- Drug discovery and development
- Precision medicine
- Agriculture and animal research
- Other applications (marine research, biofuel research, and forensics)
On the basis of End User, the genomics market has been segmented as follows:
- Research centers and academic & government institutes
- Hospitals & clinics
- Pharmaceutical & biotechnology companies
- Other end users (non-profit organizations (NPOs), agri-genomics organizations, and direct-to-consumer genetic companies)
On the basis of Region, the genomics market has been segmented as follows:
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- RoE
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Rest of the World (RoW)
- Middle East and Africa
- Latin America
Critical questions answered in the report:
- Where will all the market developments take the industry in the mid-to-long term?
- What are the upcoming products and technologies in the genomics market?
- Which application segments will dominate the market in the future?
- Emerging countries have immense opportunities for the growth and adoption of genomics solutions. Will this scenario continue in the next five years?
- Where will all the advancements in the market (offered by various companies) take the industry in the mid-to-long term?
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1 Introduction (Page No. - 17)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. - 20)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.2.1 Market Data Validation and Triangulation
2.3 Assumptions for the Study
3 Executive Summary (Page No. - 30)
4 Premium Insights (Page No. - 35)
4.1 Genomics: Market Overview
4.2 North America: Genomics Market, By Technology, 2018
4.3 Asia Pacific: Market, By Product & Service, 2018
4.4 Geographical Snapshot of the Market
5 Market Overview (Page No. - 39)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Government Funding and Growth in the Number of Genomics Projects
5.2.1.2 Decreasing Sequencing Costs
5.2.1.3 Growing Application Areas of Genomics
5.2.1.4 Entry of New Players and Start-Ups in the Genomics Market
5.2.2 Restraints
5.2.2.1 High Cost of Genomic Equipment
5.2.3 Opportunities
5.2.3.1 Use of Genomics in Specialized/Personalized Medicine
5.2.4 Challenges
5.2.4.1 Dearth of Trained Professionals
5.2.4.2 Secure Storage of Large Volumes of Sequenced Data
6 Genomics Market, By Product and Service (Page No. - 45)
6.1 Introduction
6.2 Consumables
6.2.1 Consumables Forms the Largest Segment of the Genomics Market
6.3 Systems & Software
6.3.1 With Genome Sequencing Available at Substantially Lower Rates, the Demand for Systems & Software is Expected to Increase
6.4 Services
6.4.1 The Services Segment is Expected to Grow at the Highest CAGR During the Forecast Period
7 Genomics Market, By Technology (Page No. - 53)
7.1 Introduction
7.2 PCR
7.2.1 PCR Allows Researchers to Produce Millions of Copies of A Specific Dna Sequence Within Hours
7.3 Sequencing
7.3.1 Increasing Applications of Sequencing in Animal Breeding, Agriculture, and Human Genomics to Drive Market Growth
7.4 Microarray
7.4.1 Microarray Technologies are Widely Used in the Field of Genomics Due to Their Low Cost
7.5 Nucleic Acid Extraction and Purification
7.5.1 Advances in Nucleic Acid Extraction and Purification Technologies are Expected to Support the Growth of This Market
7.6 Other Technologies
8 Genomics Market, By Application (Page No. - 62)
8.1 Introduction
8.2 Diagnostics
8.2.1 Diagnostics Forms the Largest and Fastest-Growing Application Segment of the Genomics Market
8.3 Drug Discovery and Development
8.3.1 Growing Application of Genomics in the Area of Drug Discovery and Development to Propel Market Growth
8.4 Precision Medicine
8.4.1 Precision Medicine Focuses on Identifying the Most Effective Medical Treatments for Patients Based on Their Genetic, Environmental, and Lifestyle Factors
8.5 Agriculture & Animal Research
8.5.1 Genomics Helps in Improving the Productivity of Crops and Livestock
8.6 Other Applications
9 Genomics Market, By End User (Page No. - 73)
9.1 Introduction
9.2 Research Centers and Academic & Government Institutes
9.2.1 Increase in Research Intensity to Drive the Usage of Genomics Systems Among Academic & Government Institutes
9.3 Hospitals & Clinics
9.3.1 Increasing Demand for Pharmacogenomics to Drive the Acceptance of Ngs in Hospitals
9.4 Pharmaceutical & Biotechnology Companies
9.4.1 Growing Importance of Biomarkers to Drive the Use of Genomic Systems and Services Among Pharma & Biotech Companies
9.5 Other End Users
10 Genomics Market, By Region (Page No. - 82)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 US Dominates the North American Genomics Market Due to the Increasing Research Funding and Government Initiatives for Promoting Precision Medicine and the Use of Gm Crops
10.2.2 Canada
10.2.2.1 Increasing Research in the Field of Genomics to Drive Market Growth
10.3 Europe
10.3.1 UK
10.3.1.1 UK to Register the Highest CAGR in the European Genomics Market During the Forecast Period
10.3.2 Germany
10.3.2.1 Availability of Funding for Life Sciences Research to Boost Market Growth in Germany
10.3.3 France
10.3.3.1 Increasing Government Investments in Genomics to Boost the Growth of the French Genomics Market
10.3.4 RoE
10.4 Asia Pacific
10.4.1 China
10.4.1.1 China is Expected to Command the Largest Share of the Asia Pacific Market
10.4.2 India
10.4.2.1 Emergence of Local Players is Expected to Aid the Growth of the Genomics Market in India
10.4.3 Japan
10.4.3.1 Increasing Government Focus on Cancer Research in Japan to Increase Demand for Genomics Products
10.4.4 Rest of Asia Pacific
10.5 Rest of the World
10.5.1 Middle East and Africa
10.5.1.1 Increasing Adoption of Genetic Testing in the Middle East and Rising Hiv & Cancer Incidence in Africa are Driving Market Growth
10.5.2 Latin America
10.5.2.1 Government Funding and Partnerships to Boost the Adoption of Genomics Products and Services in Latin America
11 Competitive Landscape (Page No. - 126)
11.1 Overview
11.1.1 Thermo Fisher Scientific
11.1.2 Illumina
11.1.3 Qiagen
11.1.4 Others
11.2 Competitive Scenario
11.2.1 Product Launches and Approvals
11.2.2 Expansions
11.2.3 Agreements and Collaborations
11.2.4 Acquisitions
11.3 Competitive Leadership Mapping (Overall Market) (2018)
11.3.1 Visionary Leaders
11.3.2 Innovators
11.3.3 Dynamic Differentiators
11.3.4 Emerging Companies
11.4 Competitive Benchmarking
11.4.1 Analysis of the Product Portfolio of Major Players in the Genomics Market (25 Companies)
11.4.2 Business Strategies Adopted By Major Players in the Genomics Market (25 Companies)
11.5 Competitive Leadership Mapping (Start-Up) (2018)
11.5.1 Progressive Companies
11.5.2 Starting Blocks
11.5.3 Dynamic Companies
11.5.4 Responsive Companies
12 Company Profiles (Page No. - 136)
(Business Overview, Products Offered, Service Offered Recent Developments, MnM View)*
12.1 Illumina, Inc.
12.2 Thermo Fisher Scientific
12.3 Qiagen
12.4 Eurofins Scientific
12.5 Agilent Technologies
12.6 Oxford Nanopore Technologies
12.7 F. Hoffmann-La Roche
12.8 Bio-Rad Laboratories
12.9 BGI
12.10 Danaher Corporation
12.11 Ge Healthcare
12.12 Eppendorf
*Business Overview, Products Offered, Service Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.
13 Appendix (Page No. - 185)
13.1 Discussion Guide
13.2 Knowledge Store: Marketsandmarkets Subscription Portal
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details
List of Tables (95 Tables)
Table 1 Genomics Market, By Product and Service, 20172024 (USD Million)
Table 2 Market for Consumables, By Country, 20172024 (USD Million)
Table 3 Market for Systems/Software, By Country, 20172024 (USD Million)
Table 4 Market for Services, By Country, 20172024 (USD Million)
Table 5 Market, By Technology, 20172024 (USD Million)
Table 6 Market for PCR, By Country, 20172024 (USD Million)
Table 7 Market for Sequencing, By Country, 20172024 (USD Million)
Table 8 Market for Microarray, By Country, 20172024 (USD Million)
Table 9 Market for Nucleic Acid Extraction and Purification, By Country, 20172024 (USD Million)
Table 10 Market for Other Technologies, By Country, 20172024 (USD Million)
Table 11 Market, By Application, 20172024 (USD Million)
Table 12 Market for Diagnostics, By Country, 20172024 (USD Million)
Table 13 Market for Drug Discovery and Development, By Country, 20172024 (USD Million)
Table 14 Market for Precision Medicine, By Country, 20172024 (USD Million)
Table 15 Market for Agriculture & Animal Research, By Country, 20172024 (USD Million)
Table 16 Market for Other Applications, By Country, 20172024 (USD Million)
Table 17 Market, By End User, 20172024 (USD Million)
Table 18 Market for Research Centers and Academic & Government Institutes, By Country, 20172024 (USD Million)
Table 19 Market for Hospitals & Clinics, By Country, 20172024 (USD Million)
Table 20 Market for Pharmaceutical & Biotechnology Companies, By Country, 20172024 (USD Million)
Table 21 Market for Other End Users, By Country, 20172024 (USD Million)
Table 22 Market, By Region, 20172024 (USD Million)
Table 23 North America: Market, By Country, 20172024 (USD Million)
Table 24 North America: Market, By Product & Service, 20172024 (USD Million)
Table 25 North America: Market, By Technology, 20172024 (USD Million)
Table 26 North America: Market, By Application, 20172024 (USD Million)
Table 27 North America: Genomics Market, By End User, 20172024 (USD Million)
Table 28 US: Market, By Product & Service, 20172024 (USD Million)
Table 29 US: Market, By Technology, 20172024 (USD Million)
Table 30 US: Market, By Application, 20172024 (USD Million)
Table 31 US: Genomics Market, By End User, 20172024 (USD Million)
Table 32 Indicative List of Projects Funded By Gapp in 2018
Table 33 Canada: Market, By Product & Service, 20172024 (USD Million)
Table 34 Canada: Market, By Technology, 20172024 (USD Million)
Table 35 Canada: Market, By Application, 20172024 (USD Million)
Table 36 Canada: Market, By End User, 20172024 (USD Million)
Table 37 Europe: Market, By Country, 20172024 (USD Million)
Table 38 Europe: Market, By Product & Service, 20172024 (USD Million)
Table 39 Europe: Market, By Technology, 20172024 (USD Million)
Table 40 Europe: Market, By Application, 20172024 (USD Million)
Table 41 Europe: Genomics Market, By End User, 20172024 (USD Million)
Table 42 UK: Market, By Product & Service, 20172024 (USD Million)
Table 43 UK: Market, By Technology, 20172024 (USD Million)
Table 44 UK: Market, By Application, 20172024 (USD Million)
Table 45 UK: Market, By End User, 20172024 (USD Million)
Table 46 Germany: Market, By Product & Service, 20172024 (USD Million)
Table 47 Germany: Market, By Technology, 20172024 (USD Million)
Table 48 Germany: Market, By Application, 20172024 (USD Million)
Table 49 Germany: Market, By End User, 20172024 (USD Million)
Table 50 France: Market, By Product & Service, 20172024 (USD Million)
Table 51 France: Market, By Technology, 20172024 (USD Million)
Table 52 France : Market, By Application, 20172024 (USD Million)
Table 53 France: Market, By End User, 20172024 (USD Million)
Table 54 RoE: Market, By Product & Service, 20172024 (USD Million)
Table 55 RoE: Market, By Technology, 20172024 (USD Million)
Table 56 RoE: Market, By Application, 20172024 (USD Million)
Table 57 RoE: Genomics Market, By End User, 20172024 (USD Million)
Table 58 Asia Pacific: Market, By Country, 20172024 (USD Million)
Table 59 Asia Pacific: Market, By Product & Service, 20172024 (USD Million)
Table 60 Asia Pacific: Market, By Technology, 20172024 (USD Million)
Table 61 Asia Pacific: Market, By Application, 20172024 (USD Million)
Table 62 Asia Pacific: Market, By End User, 20172024 (USD Million)
Table 63 China: Market, By Product & Service, 20172024 (USD Million)
Table 64 China: Market, By Technology, 20172024 (USD Million)
Table 65 China: Market, By Application, 20172024 (USD Million)
Table 66 China: Market, By End User, 20172024 (USD Million)
Table 67 India: Market, By Product & Service, 20172024 (USD Million)
Table 68 India: Market, By Technology, 20172024 (USD Million)
Table 69 India: Market, By Application, 20172024 (USD Million)
Table 70 India: Market, By End User, 20172024 (USD Million)
Table 71 Japan: Market, By Product & Service, 20172024 (USD Million)
Table 72 Japan: Market, By Technology, 20172024 (USD Million)
Table 73 Japan: Market, By Application, 20172024 (USD Million)
Table 74 Japan: Genomics Market, By End User, 20172024 (USD Million)
Table 75 RoAPAC: Market, By Product & Service, 20172024 (USD Million)
Table 76 RoAPAC: Market, By Technology, 20172024 (USD Million)
Table 77 RoAPAC: Market, By Application, 20172024 (USD Million)
Table 78 RoAPAC: Market, By End User, 20172024 (USD Million)
Table 79 RoW: Market, By Region, 20172024 (USD Million)
Table 80 RoW: Market, By Product & Service, 20172024 (USD Million)
Table 81 RoW: Market, By Technology, 20172024 (USD Million)
Table 82 RoW: Market, By Application, 20172024 (USD Million)
Table 83 RoW: Market, By End User, 20172024 (USD Million)
Table 84 Middle East and Africa: Market, By Product & Service, 20172024 (USD Million)
Table 85 Middle East and Africa: Market, By Technology, 20172024 (USD Million)
Table 86 Middle East and Africa: Market, By Application, 20172024 (USD Million)
Table 87 Middle East and Africa: Genomics Market, By End User, 20172024 (USD Million)
Table 88 Latin America: Market, By Product & Service, 20172024 (USD Million)
Table 89 Latin America: Market, By Technology, 20172024 (USD Million)
Table 90 Latin America: Market, By Application, 20172024 (USD Million)
Table 91 Latin America: Market, By End User, 20172024 (USD Million)
Table 92 Product Launches and Approvals
Table 93 Expansions
Table 94 Agreements and Collaborations
Table 95 Acquisitions
List of Figures (38 Figures)
Figure 1 Market Segmentation
Figure 2 Market: Research Methodology
Figure 3 Research Design
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Market Size Estimation Methodology: Bottom-Up Approach
Figure 6 Market Size Estimation Methodology: Top-Down Approach
Figure 7 Data Triangulation Methodology
Figure 8 Market, By Product & Service, 2018
Figure 9 Market, By Technology, 2018
Figure 10 Market, By Application, 2018
Figure 11 Market, By End User, 2018
Figure 12 Geographical Snapshot of the Genomics Market
Figure 13 Rising Government Funding and Growth in the Number of Genomics Projects to Drive Market Growth During the Forecast Period
Figure 14 PCR Segment Accounted for the Largest Share of the North American Genomics Market in 2018
Figure 15 Consumables Segment Commanded the Largest Share of the Asia Pacific Genomics Market in 2018
Figure 16 Asia Pacific to Witness the Highest Growth During the Forecast Period
Figure 17 Consumables to Command the Largest Share of the Market in 2019
Figure 18 PCR Segment Will Continue to Dominate the Market in the Forecast Period
Figure 19 Diagnostic Applications to Dominate the Market During the Forecast Period
Figure 20 Research Centers and Academic & Government Institutes to Command the Largest Share of the Market in 2019
Figure 21 North America Will Continue to Dominate the Genomics Market During the Forecast Period
Figure 22 North America: Market Snapshot
Figure 23 Europe: Market Snapshot
Figure 24 Asia Pacific: Market Snapshot
Figure 25 RoW: Market Snapshot
Figure 26 Market Share Analysis, By Key Player, 2018
Figure 27 Competitive Leadership Mapping: Market
Figure 28 Competitive Leadership Mapping: Genomics Market
Figure 29 Illumina, Inc.: Company Snapshot (2018)
Figure 30 Thermo Fisher Scientific, Inc.: Company Snapshot (2017)
Figure 31 Qiagen N.V.: Company Snapshot (2017)
Figure 32 Eurofins Scientific: Company Snapshot (2017)
Figure 33 Agilent Technologies : Company Snapshot (2017)
Figure 34 Roche Holding AG: Company Snapshot (2017)
Figure 35 Bio-Rad Laboratories, Inc.: Company Snapshot (2017)
Figure 36 Danaher Corporation: Company Snapshot (2017)
Figure 37 General Electrical Company: Company Snapshot (2017)
Figure 38 Eppendorf AG: Company Snapshot (2017)
The study involved four major activities to estimate the current size of the genomics market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources such as D&B Hoovers, Bloomberg Business, and Factiva have been referred to so as to identify and collect information for this study. These secondary sources included annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases.
Primary Research
The genomics market comprises several stakeholders such as healthcare IT service providers and healthcare institutions/providers (hospitals, medical groups, physician practices, diagnostic centers, pharmacies, ambulatory centers, and outpatient clinics). Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. Following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the genomics market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and markets have been identified through extensive secondary research
- The industrys supply chain and market size, in terms of value, have been determined through primary and secondary research processes
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Data Triangulation
After arriving at the overall market sizeusing the market size estimation processes as explained abovethe market was split into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the genomics industry.
Report Objectives
- To define, describe, and forecast the genomics market on the basis of product & service, application, technology, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the genomics market with respect to four main regionsNorth America, Europe, Asia Pacific, and the Rest of the World
- To profile the key players in the genomics market and comprehensively analyze their core competencies
- To track and analyze competitive developments such as agreements and partnerships, mergers, and acquisitions of the leading players in the precision medicine software market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the companys specific needs. The following customization options are available for the report:
Portfolio Analysis
- Product Matrix, which gives a detailed comparison of the product portfolio of each company
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Get in-depth analysis of the COVID-19 impact on the Genomics Market
Benchmarking the rapid strategy shifts of the Top 100 companies in the Genomics Market
Request For Special Pricing
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Genomics Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Genomics Market